Doris Feineis
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 2%
- Axial and Atropisomeric Chirality Synthesis
- Chemical synthesis and alkaloids
Papers in
-
- Axial and Atropisomeric Chirality Synthesis 37
- Chemical synthesis and alkaloids 9
-
- Synthesis and bioactivity of alkaloids 11
- Sphingolipid Metabolism and Signaling 10
- Cancer therapeutics and mechanisms 10
- Co-authors
- Gerhard Bringmann (76 shared papers)Virima Mudogo (15 shared papers)Reto Brun (15 shared papers)Blaise Kimbadi Lombe (8 shared papers)Suresh Awale (13 shared papers)Marcel Kaiser (14 shared papers)Shaimaa Fayez (14 shared papers)Thomas Efferth (10 shared papers)
- Journals
- Journal of Natural Products (10 papers)RSC Advances (5 papers)Fitoterapia (5 papers)Tetrahedron (3 papers)Bioorganic & Medicinal Chemistry (3 papers)
- Partner nations
- GermanyDemocratic Republic of the CongoSwitzerland
In The Last Decade
Doris Feineis
81 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 95
- Toxicology 105
- Organic Chemistry 801
- Biochemistry 161
- Spectroscopy 321
- Pharmacology 130
Countries citing papers authored by Doris Feineis
This map shows the geographic impact of Doris Feineis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Feineis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Feineis more than expected).
Fields of papers citing papers by Doris Feineis
This network shows the impact of papers produced by Doris Feineis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Feineis. The network helps show where Doris Feineis may publish in the future.
Co-authors
The 25 scholars most cited alongside Doris Feineis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 65 | |
| 2 | 2018 | 60 | |
| 3 | 2017 | 59 | |
| 4 | 2022 | 49 | |
| 5 | 2002 | 47 | |
| 6 | 2001 | 43 | |
| 7 | 2016 | 42 | |
| 8 | 1998 | 40 | |
| 9 | 2019 | 37 | |
| 10 | 2000 | 36 | |
| 11 | 2017 | 33 | |
| 12 | 2017 | 33 | |
| 13 | 2018 | 33 | |
| 14 | 2018 | 31 | |
| 15 | The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. | 1995 | 28 |
| 16 | 1998 | 28 | |
| 17 | 2009 | 27 | |
| 18 | 2017 | 26 | |
| 19 | 2018 | 26 | |
| 20 | 2017 | 26 |
About Doris Feineis
Doris Feineis is a scholar working on Organic Chemistry, Molecular Biology, Spectroscopy, Biochemistry and Cellular and Molecular Neuroscience, having authored 83 papers that have together received 1.4k indexed citations. Recurring topics across this work include Axial and Atropisomeric Chirality Synthesis (37 papers), Molecular spectroscopy and chirality (18 papers), Traditional and Medicinal Uses of Annonaceae (16 papers), Neuroscience and Neuropharmacology Research (16 papers), Synthesis and bioactivity of alkaloids (11 papers), Sphingolipid Metabolism and Signaling (10 papers), Cancer therapeutics and mechanisms (10 papers) and Chemical synthesis and alkaloids (9 papers). The work is most often cited by research in Toxicology (105 citations), Organic Chemistry (801 citations), Biochemistry (161 citations), Spectroscopy (321 citations) and Pharmacology (130 citations). Doris Feineis has collaborated with scholars based in Germany, Democratic Republic of the Congo and Switzerland. Frequent co-authors include Gerhard Bringmann, Virima Mudogo, Reto Brun, Blaise Kimbadi Lombe, Suresh Awale, Marcel Kaiser, Shaimaa Fayez, Thomas Efferth, Ean‐Jeong Seo and Ralf God. Their work appears in journals such as Journal of Natural Products, RSC Advances, Fitoterapia, Tetrahedron and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.